Medicines Discovery Catapult (MDC) is enabling the community to reshape medicines discovery in the UK. It is ambitious, and it is achievable.
We do this by championing innovative life science technology and new approaches, supporting UK innovators to succeed.
We are helping to industrialise and drive the adoption of new techniques and technologies.
We are driven by helping our community make their mark on the industry and patients.If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.
A Beacon of Light for Employment: Alderley Park Lighthouse Lab to generate employment opportunities for North-West life sciences sector
The Alderley Park Lighthouse Lab in Cheshire plays a key role in supporting the government’s drive to increase UK testing capacity. The facility, operated by
Oncimmune and Medicines Discovery Catapult awarded UK Government funding for development of an Infectious Disease research tool for use in COVID-19
Validated research tool to be used to predict disease severity and individual therapeutic response to COVID-19 in aid of rapid vaccine and drug development Oncimmune
Sixfold Bioscience and Medicines Discovery Catapult (MDC) awarded Innovate UK grant to pursue ground-breaking project Sixfold Bioscience in partnership with MDC, has been given the